Similar Items: Study of genetic modifiers of fetal hemoglobin and mechanisms of hydroxyurea-induced γ-globin expression in sickle cell disease
- Pharmacogenomics of sickle cell disease therapeutics: pain and drug metabolism associated gene variants and hydroxyurea-induced post-transcriptional expression of miRNAs
- Genomics of sickle cell disease and fetal hemoglobin in African populations
- The role of social determinants of health in hydroxyurea adherence among persons with sickle cell disease: A systematic review
- Left ventricular strain and chamber dimensions in pediatric sickle cell disease: age-related reduction in myocardial deformation independent of hemolysis and hydroxyurea therapy
- The fate of genetically modified yeast in the environment
- Current Status of Clinical Gene Therapy for Hemophilia and Globin Disorders
Author: Wonkam, Ambroise
- Association of variants in APOL1, MYH9 and HMOX1 WITH micro-Albuminuria among Sickle Cell disease patients from Cameroon
- Sickle cell anaemia in Cameroon : co-inheritance of α-thalassemia, HBB gene haplotypes, clinical & haematological characterisations
- Study of genetic modifiers of fetal hemoglobin and mechanisms of hydroxyurea-induced γ-globin expression in sickle cell disease
- Return of a Fragile X Syndrome Genetic Result: Exploring the feedback of Individual genetic findings and their relation to traditional knowledge in a village in Cameroon
- The genetics of non-syndromic hearing impairment in South Africa
- Knowledge and experiences of parents with children affected by Sickle Cell Disease in Cape Town